Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,840 total articles
InflaRx N.V. announced new preclinical data showing that izicopan, their investigational oral C5aR1 inhibitor, demonstrates minimal reactive metabolite formation in human liver microsomes, indicating a potentially safer bioactivation profile compared to the marketed drug avacopan. Izicopan has shown strong pharmacokinetic/pharmacodynamic and safety…
FG Nexus has formed a Special Committee of independent directors to evaluate strategic alternatives, including a potential business combination with FG Communities, a real estate investment company focused on manufactured affordable housing communities. The combination aims to build a leading platform integrating income-producing affordable housing…
Rekor Systems has secured a $16.8 million contract with the Oklahoma District Attorneys Council to continue providing technology for the state's Uninsured Vehicle Enforcement Diversion (UVED) Program. Utilizing advanced AI-powered vehicle recognition sensors, Rekor's technology helps identify uninsured drivers, reducing uninsured motorist rates and…
Hubbell Incorporated announced the acquisition of NSI Industries, a leading manufacturer of electrical fittings and components, for $3 billion in cash. The transaction is expected to strengthen Hubbell's Electrical Solutions segment by adding complementary products and brands, supporting long-term growth driven by electrification trends. The deal i…
Palvella Therapeutics has initiated patient dosing in the Phase 2 LOTU trial evaluating its Fast Track-designated QTORIN™ 3.9% rapamycin anhydrous gel for treating clinically significant angiokeratomas, a rare and debilitating vascular malformation with no approved therapies. The single-arm trial plans to enroll up to 15 patients at U.S. vascular a…
K Wave Media Ltd. (NASDAQ: KWM) announced a strategic transformation involving the sale of its legacy business Play Co., Ltd., eliminating approximately $48 million in debt, and a pivot towards developing and investing in AI infrastructure. The company secured expanded capital access of up to $485 million from Anson Funds to fund this AI infrastruc…
BridgeBio Pharma announced new data presentations from the Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy at the upcoming ESC Heart Failure 2026 conference. The data highlights acoramidis' positive impact on heart failure progression, biomarkers, and clinical outcomes, supporting its established role in reducing c…
MacroGenics, Inc., a clinical-stage biopharmaceutical company, announced an expanded royalty purchase agreement with Sagard Healthcare Partners involving its cancer drug ZYNYZ® (retifanlimab-dlwr). The deal provides MacroGenics a $60 million upfront payment and potential additional milestones, while Sagard receives capped royalty interests on globa…
L.B. Foster Company announced strong financial results for Q1 2026 with net sales rising 23.9% to $121.1 million, driven primarily by a 38.4% increase in Rail segment sales. The company reported net income of $1.5 million, a significant turnaround from a loss last year, and EBITDA growth of 183%, supported by increased volume and improved gross pro…
Micropolis AI Robotics, a UAE-based autonomous mobile robot developer listed on NYSE American, announces the launch of its next-generation M1.5 hybrid robot. This enhanced platform features improved off-road mobility, higher endurance, and operational resilience tailored for mission-critical applications in security, surveillance, and industrial en…
Healthcare Realty Trust Incorporated, a leading U.S. owner and operator of medical outpatient buildings, announced a private offering of $500 million in exchangeable senior notes due 2032. The proceeds will be used partly to enter capped call transactions, repurchase up to $75 million of common stock, and refinance existing debt due in 2026. The of…
Compass Diversified (NYSE: CODI) finalized the sale of its majority-owned subsidiary Sterno's food service business to Archer Foodservice Partners for approximately $280 million after adjustments. The proceeds will be used to repay senior secured debt, reducing the company's net leverage ratio to below 1.0x by June 30, 2026, avoiding fees related t…
SOLV Energy, a Nasdaq-listed infrastructure services provider for the power industry, will release its first quarter 2026 financial results on May 12, 2026, followed by a management conference call and webcast. The company specializes in engineering, procurement, construction, operations, maintenance, and repowering of power infrastructure.
NextCure, Inc. in partnership with Simcere Zaiming Pharmaceutical have initiated the dose optimization phase of their Phase 1 clinical trial for SIM0505, an antibody drug conjugate targeting cadherin-6 for treating platinum-resistant ovarian cancer. SIM0505 has received Fast Track designation from the FDA, and the companies are expanding their clin…
Pasithea Therapeutics, a US-based clinical-stage biotech company, announced the appointment of Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer. Dr. Krishnan brings extensive experience in clinical development, particularly with MEK inhibitors, having contributed to the FDA approval of cobimetinib. He will oversee clinical strategy for PAS-00…
Indivior Pharmaceuticals announced a $175 million accelerated share repurchase agreement with Barclays, utilizing part of its ongoing $400 million buyback program. The company aims to demonstrate confidence in its long-term strategy and financial strength without altering prior financial guidance. The ASR will initially repurchase 3.7 million share…
Axsome Therapeutics reported a robust first quarter of 2026 with total net product revenue growing 57% year-over-year to $191.2 million. The company highlighted the FDA approval of Auvelity for agitation associated with dementia due to Alzheimer's disease, positioning it as a first-in-class treatment. Axsome expanded its commercial efforts and adde…
Superior Group of Companies, Inc. reported its Q1 2026 results showing net sales increase to $140.9 million from $137.1 million a year ago, with net income turning positive at $0.8 million compared to a net loss previously. EBITDA rose to $4.8 million. The company confirmed its full-year 2026 sales and earnings outlook with net sales expected betwe…
ADMA Biologics announced that the FDA has approved the supplemental Biologics License Application for ASCENIV™, expanding its indication for primary humoral immunodeficiency (PI) to include pediatric patients aged two years and older, down from twelve years. This approval follows the final pediatric assessment study report, fulfilling post-marketin…
Seer, Inc. announced the hiring of Anthony Bazarko as Chief Commercial Officer. Bazarko brings over 20 years of leadership experience in life sciences and diagnostics, including prior executive roles at Biologos and Specific Diagnostics. At Seer, he will lead Sales, Marketing, and Customer Experience to boost adoption of Seer's Proteograph® Product…
SOLV Energy announced its agreement to acquire Roberson Waite Electric, a California-based utility substation construction and services provider. This acquisition expands SOLV’s capabilities into the regulated utility market, enhancing its service offerings in grid modernization and resilience, and supports its long-term growth strategy.
Haleon, a global consumer health leader, has introduced the newly reformulated Centrum Adults 50+ Complete Multivitamin in Canada, designed to support nutritional needs and cognitive health of adults aged 50 and over. The formulation is backed by clinical trials demonstrating memory and brain health benefits, continuing Haleon's commitment to scien…
Seres Therapeutics announced preclinical data supporting SER-603, a novel live biotherapeutic candidate designed to target microbial functions linked to mucosal healing and inflammation in inflammatory bowel disease (IBD). Presented at Digestive Disease Week 2026, the data demonstrate SER-603’s potential for precise modulation of inflammatory pathw…
Tilray's craft beer brand 10 Barrel Brewing introduces two new ready-to-drink cocktails—Clean Slate, a non-alcoholic functional beverage infused with vitamins and natural energizers, and Salty Sips, a low-sugar, low-ABV vodka cocktail. These products target changing consumer preferences towards functional, health-conscious drinks and aim to expand …
Prospect Capital Corporation, a US-based business development company, has completed a $26 million investment in Security Fire Systems, collaborating with Blackford Capital. The investment includes a senior secured term loan and preferred equity to finance SFS's growth and acquisition plans in the fire suppression industry across multiple states an…
